Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 10, Issue 5, 2011, Pages 370-376

  Viviani, Laura ^a   Assael, Baroukh M ^b   Kerem, Eitan ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

A(H1N1); Cystic fibrosis; Influenza

Indexed keywords

ANTIBIOTIC AGENT; INFLUENZA VACCINE; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; AUSTRIA; BELGIUM; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DETERIORATION; DISEASE COURSE; DISEASE EXACERBATION; FATALITY; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; FRANCE; GERMANY; HOSPITALIZATION; HUMAN; INFECTION RATE; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; ISRAEL; ITALY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OXYGEN THERAPY; PORTUGAL; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SPAIN; UNITED KINGDOM; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EUROPE; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; PANDEMICS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 80052478907     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.06.004     Document Type: Article

References (39)

1. Trifonov V., Khiabanian H., Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med 2009, 361(2):115-119.
2. Shinde V., Bridges C.B., Uyeki T.M., Shu B., Balish A., Xu X., et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009, 360(25):2616-2625.
3. Prevention USCfDCa. Key facts about seasonal influenza (Flu) cited; Available from. http://www.cdc.gov/flu/keyfacts.htm.
4. Perez-Padilla R., de la Rosa-Zamboni D., Ponce de Leon S., Hernandez M., Quinones-Falconi F., Bautista E., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361(7):680-689.
5. World Health Organization Pandemic (H1N1) 2009-update 77 cited; available from:, Accessed August 5, 2010. http://www.who.int/csr/don/2010_07_30/en/index.html.
6. Prevention CfDCa cited; Available from, Accessed August 5, 2010. http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm.
7. Louie J.K., Jean C., Acosta M., Samuel M.C., Matyas B.T., Schechter R. A review of adult mortality due to 2009 pandemic (H1N1) influenza A in California. PLoS ONE 2011 Apr 5, 6(4):e18221.
8. Donaldson L.J., Rutter P.D., Ellis B.M., Greaves F.E., Mytton O.T., Pebody R.G., et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ (Clinical research ed.) 2009, 339:b5213.
9. Brundage J.F. Cases and deaths during influenza pandemics in the United States. Am J Prev Med 2006, 31(3):252-256.
10. Control ECfDPa Weekly influenza surveillance overview 2010.
11. Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361(20):1935-1944.
12. Webb S.A., Pettila V., Seppelt I., Bellomo R., Bailey M., Cooper D.J., et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361(20):1925-1934.
13. Bhat N., Wright J.G., Broder K.R., Murray E.L., Greenberg M.E., Glover M.J., et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005, 353(24):2559-2567.
14. Conway S.P., Simmonds E.J., Littlewood J.M. Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax 1992, 47(2):112-114.
15. Marshall B.C., Henshaw C., Evans D.A., Bleyl K., Alder S., Liou T.G. Influenza vaccination coverage level at a cystic fibrosis center. Pediatrics 2002, 109(5):E80-80.
16. Murris-Espin M., Aubert M., Bosdure E., Dubus J.C. Influenza vaccination coverage in patients with cystic fibrosis followed at 12 care centers in the Greater South Region of France for the season 2005/2006. Vaccine 2008, 26(44):5612-5618.
17. France M.W., Tai S., Masel P.J., Moore V.L., McMahon T.L., Ritchie A.J., et al. The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis. BMC Pulmonary Medicine 2010 Feb 25, 10:8.
18. Nash E.F., Whitmill R., Barker B., Rashid R., Whitehouse J.L., Honeybourne D. Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis. Thorax 2011 Mar, 66(3):259.
19. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159(1):179-187.
20. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18years of age. Pediatr Pulmonol 1993, 15(2):75-88.
21. Venkata C., Sampathkumar P., Afessa B. Hospitalized patients with 2009 H1N1 influenza infection: the Mayo Clinic experience. Mayo Clinic Proceedings 2010 Sep, 85(9):798-805.
22. Nin N, Soto L, Hurtado J, Lorente JA, Buroni M, Arancibia F, et al. Clinical characteristics and outcomes of patients with 2009 influenza A(H1N1) virus infection with respiratory failure requiring mechanical ventilation. Journal of critical care: 26(2): 186-192.
23. Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, Foster K, et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill: 15(20).
24. Diaz E, Rodriguez A, Martin-Loeches I, Lorente L, del Mar Martin M, Pozo JC, et al. Impact of obesity in patients infected with 2009 influenza A(H1N1). Chest: 139(2): 382-386.
25. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ (Clinical research ed.) 2009, 340:c1279.
26. Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, Semple MG, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax: 65(7): 645-651.
27. Ramsey B.W., Gore E.J., Smith A.L., Cooney M.K., Redding G.J., Foy H. The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child 1989, 143(6):662-668. (1960).
28. Hiatt P.W., Grace S.C., Kozinetz C.A., Raboudi S.H., Treece D.G., Taber L.H., et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999, 103(3):619-626.
29. Hordvik N.L., Konig P., Hamory B., Cooperstock M., Kreutz C., Gayer D., et al. Effects of acute viral respiratory tract infections in patients with cystic fibrosis. Pediatr Pulmonol 1989, 7(4):217-222.
30. van Ewijk B.E., van der Zalm M.M., Wolfs T.F., Fleer A., Kimpen J.L., Wilbrink B., et al. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics 2008, 122(6):1171-1176.
31. Petersen N.T., Hoiby N., Mordhorst C.H., Lind K., Flensborg E.W., Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, Chlamydia and Mycoplasma-possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand 1981, 70(5):623-628.
32. Ortiz J.R., Neuzil K.M., Victor J.C., Wald A., Aitken M.L., Goss C.H. Influenza-associated cystic fibrosis pulmonary exacerbations. Chest 2010 Apr, 137(4):852-860.
33. Du N., Zhou J., Lin X., Zhang Y., Yang X., Wang Y., et al. Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. Journal of Virology 2010 Aug, 84(15):7822-7831.
34. ECFS ECs [cited accessed September 13th 2010]; available from. http://www.ecfs.eu/files/webfm/webfiles/File/ecfs_registry/ECFRreport2007final.pdf.
35. Lemaitre M., Carrat F. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infectious Diseases 2010 Jun 9, 10:162.
36. Ortiz J.R., Neuzil K.M., Victor J.C., Aitken M.L., Goss C.H. Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007. Chest 2010 Dec, 138(6):1448-1455.
37. Schwarzinger M., Flicoteaux R., Cortarenoda S., Obadia Y., Moatti J.P. Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance?. PLoS ONE 2010 Apr 16, 5(4):e10199.
38. Ling L.M., Chow A.L., Lye D.C., Tan A.S., Krishnan P., Cui L., et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010 Apr 1, 50(7):963-969.
39. Murris-Espin M., Maitre M., Bosdure E., Dubus J.C. Influenza vaccination in healthcare workers: a survey of coverage in French cystic fibrosis treatment centres. Vaccine 2007, 25(25):4755-4756.